Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progress toward active or passive HIV-1 vaccination.

The Journal of experimental medicine - 1 Jan 2017

Escolano Amelia, Dosenovic Pia, Nussenzweig Michel C

Abstract excerpt

AIDS is a preventable disease. Nevertheless, according to UNAIDS, 2.1 million individuals were infected with HIV-1 in 2015 worldwide. An effective vaccine is highly desirable. Most vaccines in clinical use today prevent infection because they elicit antibodies that block pathogen entry. Consistent with this general rule, studies in experimental animals have shown that broadly neutralizing antibodies to HIV-1 can...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Antibodies, Monoclonal
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Engineering

Share to HIV Antibodies

Share to Immunization, Passive

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 28003309
DOI: 10.1084/jem.20161765
PMCID: PMC5206506

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progress toward active or passive HIV-1 vaccination.PMID 28003309Read ↗

Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.Semantic proximity Read ↗

Translational research insights from completed HIV vaccine efficacy trials.Semantic proximity Read ↗

Harnessing the protective potential of HIV-1 neutralizing antibodiesSemantic proximity Read ↗

HIV/AIDS Vaccines: 2018.Semantic proximity Read ↗

The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and PreventionSemantic proximity Read ↗

Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.Semantic proximity Read ↗

[Designing an effective AIDS vaccine: strategies and current status].Semantic proximity Read ↗

Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.Semantic proximity Read ↗

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.Semantic proximity Read ↗

HIV immunology better understood and vaccination attempts started.Semantic proximity Read ↗

Can we use structural knowledge to design a protective vaccine against HIV-1?Semantic proximity Read ↗

HIV-1 vaccine immunogen design strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.